FDA Inspection
Abbott Ireland LimitedAbbott Ireland Limited – FDA Inspection, Jan 27, 2023
Record Details
This FDA Inspection record concerns Abbott Ireland Limited, with an inspection on January 27, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · e284dd69-e449-4d17-946b-32d06b5b8158
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1203661
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Abbott Ireland Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 14, 2025 | Not classified | Office of Inspections and Investigations | |
| August 27, 2018 | Not classified | Office of Inspections and Investigations | |
| March 2, 2017 | Not classified | Office of Inspections and Investigations | |
| February 6, 2014 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| September 20, 2012 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Abbott Ireland Limited
- FDA Inspection 1263518 - 2025-02-14
- FDA Inspection 1074939 - 2018-08-27
- FDA Inspection 1010736 - 2017-03-02
- FDA Inspection 865230 - 2014-02-06
- FDA Inspection 803895 - 2012-09-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.